Filtering by:
Prostate CancerFacts & Figures 2019: US Cancer Death Rate has Dropped 27% in 25 Years
The death rate from cancer in the US has declined steadily over the past 25 years, according to annual statistics reporting from the American Cancer Society.
New Prostate Cancer Guideline Offers Shortened Radiation Time
Men being treated for early-stage prostate cancer with external beam radiation therapy (EBRT) can safely choose an option that reduces the number of treatment sessions, according to a panel of experts from the American Society for Radiation Oncology, American Society of Clinical Oncology, and American Urological Association.
Annual Report to the Nation: Cancer Death Rates Continue Long Decline
The death rate from cancer in the United States is continuing to fall among men, women, and children, according to the latest Annual Report to the Nation on the Status of Cancer.
FDA Approves Consumer Test for Certain BRCA Mutations
The US Food and Drug Administration (FDA) has approved the first direct-to-consumer tests for certain BRCA1 and BRCA2 gene mutations.
FDA Approves Erleada (Apalutamide) for Some Prostate Cancers
The US Food and Drug Administration (FDA) has approved Erleada (apalutamide) to treat men with non-metastatic castration-resistant prostate cancer.
Facts & Figures 2018: Rate of Deaths From Cancer Continues Decline
The death rate from cancer in the US has declined steadily over the past 2 decades, according to annual statistics reporting from the American Cancer Society.
Study: Observation as Good as Surgery in Early-stage Prostate Cancer
A major 20-year study led by the Minneapolis Veterans Affairs Health Care System has found more evidence that surgery for early-stage prostate cancer does not help men live longer than observation.
Prostate Cancer Screening FAQ
The American Cancer Society, along with other leading medical organizations, recommends informed decision-making when it comes to screening for prostate cancer.